Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Director/PDMR Shareholding

11 Feb 2010 09:00

RNS Number : 0084H
Oxford Catalysts Group PLC
11 February 2010
 



11th February 2010

 

OXFORD CATALYSTS GROUP PLC

 ("Oxford Catalysts" or "the Group")

 

Director Share Dealings

 

Susan Robertson, Chief Financial Officer, has today exercised 121,361 share options under the Group's Share Option Schemes. The options' exercise price per ordinary share of the Group ("Ordinary Share") was £0.01.

 

Following this exercise, Susan Robertson holds 304,874 Ordinary Shares (representing 0.48% of the enlarged issued Ordinary Shares) and options over 404,998 Ordinary Shares (representing approximately 0.64% of the enlarged issued Ordinary Shares).

 

Roy Lipski, Chief Executive, has today exercised 1,512,425 share options under the Group's Share Option Schemes. Of the options exercised, 1,404,370 had an exercise price of £0.0489 per Ordinary Share and 108,055 had an exercise price of £0.01 per Ordinary Share.

 

Following this exercise, Roy Lipski holds 2,269,564 Ordinary Shares (representing 3.60% of the enlarged issued Ordinary Shares) and options over 942,000 Ordinary Shares (representing approximately 1.50% of the enlarged issued Ordinary Shares).

 

No shares in Oxford Catalysts Group PLC are being disposed of by either Susan Robertson or Roy Lipski.

 

The total number of Ordinary Shares in issue following the exercise of these options is 62,978,732.

 

- Ends -

 

For further information, please contact:

 

Roy Lipski, CEO, Oxford Catalysts

01235 841 700

Jonathan Marren/Oliver Stratton, KBC Peel Hunt (Nomad & Broker)

020 7418 8900

Billy Clegg/Alex Beagley, Financial Dynamics

020 7831 3113

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDDUUBBGGB
Date   Source Headline
10th Nov 20217:01 amRNSSAF OFFTAKE WITH IAG
10th Nov 20217:00 amRNSSAF OFFTAKE WITH SOUTHWEST AIRLINES
28th Oct 20214:40 pmRNSSecond Price Monitoring Extn
28th Oct 20214:35 pmRNSPrice Monitoring Extension
20th Oct 20214:35 pmRNSPrice Monitoring Extension
24th Sep 20217:00 amRNSInvestor Presentation
23rd Sep 20217:00 amRNSHalf-year Report
14th Sep 20217:00 amRNSUS government SAF policy support
1st Sep 20217:00 amRNSGrant of up to £2.4M awarded for Altalto project
31st Aug 20217:00 amRNSVelocys collaboration with Toyo advances
25th Aug 20217:00 amRNSE-fuels project
20th Aug 20214:40 pmRNSSecond Price Monitoring Extn
20th Aug 20214:35 pmRNSPrice Monitoring Extension
18th Aug 20214:41 pmRNSSecond Price Monitoring Extn
18th Aug 20214:35 pmRNSPrice Monitoring Extension
11th Aug 20217:00 amRNSHolding(s) in Company
3rd Aug 20219:00 amRNSApplication for Block Admission
26th Jul 20217:00 amRNSDirectorate Change
5th Jul 202111:55 amRNSBlock listing Interim Review
1st Jul 202110:00 amRNSTotal Voting Rights
30th Jun 20217:00 amRNSVelocys U.S. SAF project update
23rd Jun 20212:38 pmRNSResult of AGM
21st Jun 20217:00 amRNSVelocys technology powers first commercial flight
1st Jun 20217:00 amRNSTotal Voting Rights
27th May 20217:00 amRNSMailing of 2020 annual report and AGM notice
20th May 20211:28 pmRNSInvestor Presentation
18th May 202111:58 amRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSFinal Results
12th May 20214:40 pmRNSSecond Price Monitoring Extn
12th May 20214:35 pmRNSPrice Monitoring Extension
12th Apr 20211:51 pmRNSHolding(s) in Company
30th Mar 20218:14 amRNSVelocys and British Airways extend Altalto option
30th Mar 20217:00 amRNSVelocys and British Airways extend Altalto option
17th Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSToyo and Velocys execute a Collaboration Agreement
1st Feb 202112:17 pmRNSTotal Voting Rights
18th Jan 20217:00 amRNSStrategy/Company/Ops Update
5th Jan 202112:00 pmRNSBlock listing Interim Review
16th Dec 20207:00 amRNSChange of Adviser
15th Dec 20207:00 amRNSResolution of Ventech Trustees Claim
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
24th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:36 pmRNSPrice Monitoring Extension
2nd Nov 202011:09 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSHalf-year Report
2nd Sep 20201:59 pmRNSResults of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.